Skip to main content
Top
Published in: European Radiology 1/2017

Open Access 01-01-2017 | Magnetic Resonance

Repeatability of derived parameters from histograms following non-Gaussian diffusion modelling of diffusion-weighted imaging in a paediatric oncological cohort

Authors: Neil P. Jerome, Keiko Miyazaki, David J. Collins, Matthew R. Orton, James A. d’Arcy, Toni Wallace, Lucas Moreno, Andrew D. J. Pearson, Lynley V. Marshall, Fernando Carceller, Martin O. Leach, Stergios Zacharoulis, Dow-Mu Koh

Published in: European Radiology | Issue 1/2017

Login to get access

Abstract

Objectives

To examine repeatability of parameters derived from non-Gaussian diffusion models in data acquired in children with solid tumours.

Methods

Paediatric patients (<16 years, n = 17) were scanned twice, 24 h apart, using DWI (6 b-values, 0–1000 mm−2 s) at 1.5 T in a prospective study. Tumour ROIs were drawn (3 slices) and all data fitted using IVIM, stretched exponential, and kurtosis models; percentage coefficients of variation (CV) calculated for each parameter at all ROI histogram centiles, including the medians.

Results

The values for ADC, D, DDCα, α, and DDCK gave CV < 10 % down to the 5th centile, with sharp CV increases below 5th and above 95th centile. K, f, and D* showed increased CV (>30 %) over the histogram. ADC, D, DDCα, and DDCK were strongly correlated (ρ > 0.9), DDCα and α were not correlated (ρ = 0.083).

Conclusion

Perfusion- and kurtosis-related parameters displayed larger, more variable CV across the histogram, indicating observed clinical changes outside of D/DDC in these models should be interpreted with caution. Centiles below 5th for all parameters show high CV and are unreliable as diffusion metrics. The stretched exponential model behaved well for both DDCα and α, making it a strong candidate for modelling multiple-b-value diffusion imaging data.

Key Points

• ADC has good repeatability as low 5th centile of the histogram distribution.
High CV was observed for all parameters at extremes of histogram.
Parameters from the stretched exponential model showed low coefficients of variation.
The median ADC, D, DDC α , and DDC K are highly correlated and repeatable.
Perfusion/kurtosis parameters showed high CV variations across their histogram distributions.
Literature
1.
go back to reference Desar IME, ter Voert EGW, Hambrock T, van Asten JJ, van Spronsen DJ, Mulders PF et al (2001) Functional MRI techniques demonstrate early vascular changes in renal cell cancer patients treated with sunitinib: a pilot study. Cancer Imaging 11:259–265CrossRef Desar IME, ter Voert EGW, Hambrock T, van Asten JJ, van Spronsen DJ, Mulders PF et al (2001) Functional MRI techniques demonstrate early vascular changes in renal cell cancer patients treated with sunitinib: a pilot study. Cancer Imaging 11:259–265CrossRef
2.
go back to reference Jain R, Scarpace LM, Ellika S, Torcuator R, Schultz LR, Hearshen D et al (2010) Imaging response criteria for recurrent gliomas treated with bevacizumab: role of diffusion weighted imaging as an imaging biomarker. J Neurooncol 96(3):423–431CrossRefPubMed Jain R, Scarpace LM, Ellika S, Torcuator R, Schultz LR, Hearshen D et al (2010) Imaging response criteria for recurrent gliomas treated with bevacizumab: role of diffusion weighted imaging as an imaging biomarker. J Neurooncol 96(3):423–431CrossRefPubMed
3.
go back to reference Koh DM, Blackledge M, Collins DJ, Padhani AR, Wallace T, Wilton B et al (2009) Reproducibility and changes in the apparent diffusion coefficients of solid tumours treated with combretastatin A4 phosphate and bevacizumab in a two-centre phase I clinical trial. Eur Radiol 19:2728–2738CrossRefPubMed Koh DM, Blackledge M, Collins DJ, Padhani AR, Wallace T, Wilton B et al (2009) Reproducibility and changes in the apparent diffusion coefficients of solid tumours treated with combretastatin A4 phosphate and bevacizumab in a two-centre phase I clinical trial. Eur Radiol 19:2728–2738CrossRefPubMed
4.
go back to reference Pope WB, Qiao XJ, Kim HJ, Lai A, Nghiemphu P, Xue X et al (2012) Apparent diffusion coefficient histogram analysis stratifies progression-free and overall survival in patients with recurrent GBM treated with bevacizumab: a multi-center study. J Neurooncol 108:491–498CrossRefPubMedPubMedCentral Pope WB, Qiao XJ, Kim HJ, Lai A, Nghiemphu P, Xue X et al (2012) Apparent diffusion coefficient histogram analysis stratifies progression-free and overall survival in patients with recurrent GBM treated with bevacizumab: a multi-center study. J Neurooncol 108:491–498CrossRefPubMedPubMedCentral
5.
go back to reference Ellingson BM, Sahebjam S, Kim HJ, Pope WB, Harris RJ, Woodworth DC et al (2014) Pretreatment ADC histogram analysis is a predictive imaging biomarker for bevacizumab treatment but not chemotherapy in recurrent glioblastoma. AJNR Am J Neuroradiol 35(4):673–679CrossRefPubMed Ellingson BM, Sahebjam S, Kim HJ, Pope WB, Harris RJ, Woodworth DC et al (2014) Pretreatment ADC histogram analysis is a predictive imaging biomarker for bevacizumab treatment but not chemotherapy in recurrent glioblastoma. AJNR Am J Neuroradiol 35(4):673–679CrossRefPubMed
6.
go back to reference Norris RE, Adamson PC (2012) Challenges and opportunities in childhood cancer drug development. Nat Rev Cancer 12(11):776–782CrossRefPubMed Norris RE, Adamson PC (2012) Challenges and opportunities in childhood cancer drug development. Nat Rev Cancer 12(11):776–782CrossRefPubMed
7.
go back to reference Vassal G, Zwaan CM, Ashley D, Le Deley MC, Hargrave D, Blanc P et al (2013) New drugs for children and adolescents with cancer: the need for novel development pathways. Lancet Oncol 14(3):e117–e124CrossRefPubMed Vassal G, Zwaan CM, Ashley D, Le Deley MC, Hargrave D, Blanc P et al (2013) New drugs for children and adolescents with cancer: the need for novel development pathways. Lancet Oncol 14(3):e117–e124CrossRefPubMed
8.
go back to reference Boklan J (2006) Little patients, losing patience: pediatric cancer drug development. Mol Cancer Ther 5(8):1905–1908CrossRefPubMed Boklan J (2006) Little patients, losing patience: pediatric cancer drug development. Mol Cancer Ther 5(8):1905–1908CrossRefPubMed
9.
go back to reference Jost SC, Ackerman JW, Garbow JR, Manwaring LP, Gutmann DH, McKinstry RC (2008) Diffusion-weighted and dynamic contrast-enhanced imaging as markers of clinical behavior in children with optic pathway glioma. Pediatr Radiol 38(12):1293–1299CrossRefPubMed Jost SC, Ackerman JW, Garbow JR, Manwaring LP, Gutmann DH, McKinstry RC (2008) Diffusion-weighted and dynamic contrast-enhanced imaging as markers of clinical behavior in children with optic pathway glioma. Pediatr Radiol 38(12):1293–1299CrossRefPubMed
10.
go back to reference Gutierrez DR, Manita M, Jaspan T, Dineen RA, Grundy RG, Auer DP (2013) Serial MR diffusion to predict treatment response in high-grade pediatric brain tumors: a comparison of regional and voxel-based diffusion change metrics. Neuro Oncol 15(8):981–989CrossRef Gutierrez DR, Manita M, Jaspan T, Dineen RA, Grundy RG, Auer DP (2013) Serial MR diffusion to predict treatment response in high-grade pediatric brain tumors: a comparison of regional and voxel-based diffusion change metrics. Neuro Oncol 15(8):981–989CrossRef
11.
go back to reference Peet AC, Arvanitis TN, Leach MO, Waldman AD (2012) Functional imaging in adult and paediatric brain tumours. Nat Rev Clin Oncol 9(12):700–711CrossRefPubMed Peet AC, Arvanitis TN, Leach MO, Waldman AD (2012) Functional imaging in adult and paediatric brain tumours. Nat Rev Clin Oncol 9(12):700–711CrossRefPubMed
12.
go back to reference Nathan P, Zweifel M, Padhani AR, Koh D-M, Ng M, Collins DJ et al (2012) Phase I trial of combretastatin A4 phosphate (CA4P) in combination with bevacizumab in patients with advanced cancer. Clin Cancer Res 18(12):3428–3439CrossRefPubMed Nathan P, Zweifel M, Padhani AR, Koh D-M, Ng M, Collins DJ et al (2012) Phase I trial of combretastatin A4 phosphate (CA4P) in combination with bevacizumab in patients with advanced cancer. Clin Cancer Res 18(12):3428–3439CrossRefPubMed
13.
go back to reference Pope WB, Kim HJ, Alger J, Brown MS, Gjertson D, Sai V et al (2009) Recurrent glioblastoma multiforme: ADC histogram analysis predicts response to bevacizumab treatment. Neuroradiology 252(1):182–189 Pope WB, Kim HJ, Alger J, Brown MS, Gjertson D, Sai V et al (2009) Recurrent glioblastoma multiforme: ADC histogram analysis predicts response to bevacizumab treatment. Neuroradiology 252(1):182–189
14.
go back to reference Song YS, Choi SH, Park C-K, Yi KS, Lee WJ, Yun TJ et al (2013) True progression versus pseudoprogression in the treatment of glioblastomas: a comparison study of normalized cerebral blood volume and apparent diffusion coefficient by histogram analysis. Korean J Radiol 14(4):662–672CrossRefPubMedPubMedCentral Song YS, Choi SH, Park C-K, Yi KS, Lee WJ, Yun TJ et al (2013) True progression versus pseudoprogression in the treatment of glioblastomas: a comparison study of normalized cerebral blood volume and apparent diffusion coefficient by histogram analysis. Korean J Radiol 14(4):662–672CrossRefPubMedPubMedCentral
15.
go back to reference Donati OF, Mazaheri Y, Afaq A, Vargas HA, Zheng J, Moskowitz CS et al. Prostate cancer aggressiveness: assessment with whole-lesion histogram analysis of the apparent diffusion coefficient. 271(1):143–152 Donati OF, Mazaheri Y, Afaq A, Vargas HA, Zheng J, Moskowitz CS et al. Prostate cancer aggressiveness: assessment with whole-lesion histogram analysis of the apparent diffusion coefficient. 271(1):143–152
16.
go back to reference Miyazaki K, Jerome NP, Collins DJ, Orton MR, D’Arcy JA, Wallace T et al (2015) Demonstration of the reproducibility of free-breathing diffusion-weighted MRI and dynamic contrast enhanced MRI in children with solid tumours: a pilot study. Eur Radiol 25(9):2641–2650CrossRefPubMedPubMedCentral Miyazaki K, Jerome NP, Collins DJ, Orton MR, D’Arcy JA, Wallace T et al (2015) Demonstration of the reproducibility of free-breathing diffusion-weighted MRI and dynamic contrast enhanced MRI in children with solid tumours: a pilot study. Eur Radiol 25(9):2641–2650CrossRefPubMedPubMedCentral
17.
go back to reference Yankeelov TE, Lepage M, Chakravarthy A, Broome EE, Niermann KJ, Kelley MC et al (2007) Integration of quantitative DCE-MRI and ADC mapping to monitor treatment response in human breast cancer: initial results. Magn Reson Imaging 25(1):1–13CrossRefPubMed Yankeelov TE, Lepage M, Chakravarthy A, Broome EE, Niermann KJ, Kelley MC et al (2007) Integration of quantitative DCE-MRI and ADC mapping to monitor treatment response in human breast cancer: initial results. Magn Reson Imaging 25(1):1–13CrossRefPubMed
18.
go back to reference Le Bihan D, Breton E, Lallemand D, Aubin M-L, Vignaud J, Laval-Jeantet M (1988) Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging. Radiology 168(2):497–505CrossRefPubMed Le Bihan D, Breton E, Lallemand D, Aubin M-L, Vignaud J, Laval-Jeantet M (1988) Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging. Radiology 168(2):497–505CrossRefPubMed
19.
go back to reference Bennett KM, Schmainda KM, Bennett RT, Rowe DB, Lu H, Hyde JS (2003) Characterization of continuously distributed cortical water diffusion rates with a stretched-exponential model. Magn Reson Med 50(4):727–734CrossRefPubMed Bennett KM, Schmainda KM, Bennett RT, Rowe DB, Lu H, Hyde JS (2003) Characterization of continuously distributed cortical water diffusion rates with a stretched-exponential model. Magn Reson Med 50(4):727–734CrossRefPubMed
20.
go back to reference Jensen JH, Helpern JA, Ramani A, Lu H, Kaczynski K (2005) Diffusional kurtosis imaging: the quantification of non-Gaussian water diffusion by means of magnetic resonance imaging. Magn Reson Med 53:1432–1440CrossRefPubMed Jensen JH, Helpern JA, Ramani A, Lu H, Kaczynski K (2005) Diffusional kurtosis imaging: the quantification of non-Gaussian water diffusion by means of magnetic resonance imaging. Magn Reson Med 53:1432–1440CrossRefPubMed
21.
go back to reference Le Bihan D, Turner R (1992) The capillary network: a link between IVIM and classical perfusion. Magn Reson Med 27(1):171–178CrossRefPubMed Le Bihan D, Turner R (1992) The capillary network: a link between IVIM and classical perfusion. Magn Reson Med 27(1):171–178CrossRefPubMed
22.
go back to reference Limpert E, Stahel WA, Abbt M (2001) Log-normal distributions across the sciences: keys and clues. Bioscience 51(5):341CrossRef Limpert E, Stahel WA, Abbt M (2001) Log-normal distributions across the sciences: keys and clues. Bioscience 51(5):341CrossRef
23.
go back to reference Lemke A, Stieltjes B, Schad LR, Laun FB (2011) Toward an optimal distribution of b values for intravoxel incoherent motion imaging. Magn Reson Imaging 29(6):766–776CrossRefPubMed Lemke A, Stieltjes B, Schad LR, Laun FB (2011) Toward an optimal distribution of b values for intravoxel incoherent motion imaging. Magn Reson Imaging 29(6):766–776CrossRefPubMed
24.
go back to reference Freiman M, Voss SD, Mulkern RV, Perez-Rossello JM, Callahan MJ, Warfield SK (2012) In vivo assessment of optimal b-value range for perfusion-insensitive apparent diffusion coefficient imaging. Med Phys 39:4832CrossRefPubMedPubMedCentral Freiman M, Voss SD, Mulkern RV, Perez-Rossello JM, Callahan MJ, Warfield SK (2012) In vivo assessment of optimal b-value range for perfusion-insensitive apparent diffusion coefficient imaging. Med Phys 39:4832CrossRefPubMedPubMedCentral
25.
go back to reference Zhang JL, Sigmund EE, Rusinek H, Chandarana H, Storey P, Chen Q et al (2012) Optimization of b-value sampling for diffusion-weighted imaging of the kidney. Magn Reson Med 67:89–97CrossRefPubMed Zhang JL, Sigmund EE, Rusinek H, Chandarana H, Storey P, Chen Q et al (2012) Optimization of b-value sampling for diffusion-weighted imaging of the kidney. Magn Reson Med 67:89–97CrossRefPubMed
26.
go back to reference Rosenkrantz AB, Padhani AR, Chenevert TL, Koh D-M, De Keyzer F, Taouli B et al (2015) Body diffusion kurtosis imaging: basic principles, applications, and considerations for clinical practice. J Magn Reson Imaging 42(5):1190–1202CrossRefPubMed Rosenkrantz AB, Padhani AR, Chenevert TL, Koh D-M, De Keyzer F, Taouli B et al (2015) Body diffusion kurtosis imaging: basic principles, applications, and considerations for clinical practice. J Magn Reson Imaging 42(5):1190–1202CrossRefPubMed
27.
go back to reference Koh D-M, Collins DJ, Orton MR (2011) Intravoxel incoherent motion in body diffusion-weighted MRI: reality and challenges. Am J Roentgenol 196(6):1351–1361CrossRef Koh D-M, Collins DJ, Orton MR (2011) Intravoxel incoherent motion in body diffusion-weighted MRI: reality and challenges. Am J Roentgenol 196(6):1351–1361CrossRef
28.
go back to reference Cobelli C, DiStefano JJ 3rd (1980) Parameter and structural identifiability concepts and ambiguities: a critical review and analysis. Am J Physiol 239(1):R7–R24PubMed Cobelli C, DiStefano JJ 3rd (1980) Parameter and structural identifiability concepts and ambiguities: a critical review and analysis. Am J Physiol 239(1):R7–R24PubMed
29.
go back to reference Winfield JM, DeSouza NM, Priest AN, Wakefield JC, Hodgkin C, Freeman S et al (2015) Modelling DW-MRI data from primary and metastatic ovarian tumours. Eur Radiol 25:2033–2040CrossRefPubMedPubMedCentral Winfield JM, DeSouza NM, Priest AN, Wakefield JC, Hodgkin C, Freeman S et al (2015) Modelling DW-MRI data from primary and metastatic ovarian tumours. Eur Radiol 25:2033–2040CrossRefPubMedPubMedCentral
Metadata
Title
Repeatability of derived parameters from histograms following non-Gaussian diffusion modelling of diffusion-weighted imaging in a paediatric oncological cohort
Authors
Neil P. Jerome
Keiko Miyazaki
David J. Collins
Matthew R. Orton
James A. d’Arcy
Toni Wallace
Lucas Moreno
Andrew D. J. Pearson
Lynley V. Marshall
Fernando Carceller
Martin O. Leach
Stergios Zacharoulis
Dow-Mu Koh
Publication date
01-01-2017
Publisher
Springer Berlin Heidelberg
Published in
European Radiology / Issue 1/2017
Print ISSN: 0938-7994
Electronic ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-016-4318-2

Other articles of this Issue 1/2017

European Radiology 1/2017 Go to the issue